Hirofumi Kogure
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hirofumi Kogure has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Kazumichi Kawakubo
Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan
11 shared publications H. Isayama
7 shared publications- Hiroyuki Isayama
Juntendo University School of Medicine Graduate School of Medicine, Tokyo, Japan
7 shared publications K. Hirano
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
7 shared publicationsK. Koike
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
7 shared publicationsM. Tada
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
7 shared publications
Latest Publications
- 27 February 2020
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 65 (12) , 3710-3718
Retrospective Comparative Study of Side-by-Side and Stent-in-Stent Metal Stent Placement for Hilar Malignant Biliary Obstruction
Background In patients with unresectable hilar malignant biliary obstruction (MBO), bilateral metal stent placement is recommended. However, treatment selection between partially stent-in-stent (SIS) and side-by-side (SBS) methods is still controversial. Study Clinical outcomes of bilateral metal stent placement by SBS and SIS methods for hilar MBO were retrospectively studied in four Japanese centers. While large-cell-type uncovered metal stents were placed above the papilla in SIS, braided-type uncovered metal stents were placed across the papilla in SBS. Results A total of 64 patients with hilar MBO (40 SIS and 24 SBS) were included in the analysis. Technical success rate was 100% in SIS and 96% in SBS. Functional success rate was 93% in SIS and 96% in SBS. Early adverse event rates were higher in SBS (46%) than in SIS (23%), though not statistically significant (P = 0.09). Post-procedure pancreatitis was exclusively observed in SBS group (29%). Recurrent biliary obstruction rates were 48% and 43%, and the median time to recurrent biliary obstruction was 169 and 205 days in SIS and SBS, respectively. Conclusions Other than a trend to higher adverse event rates including post-procedure pancreatitis in SBS, clinical outcomes of SIS and SBS methods were comparable in patients with unresectable hilar MBO.
- 27 February 2020
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 65 (12) , 3710-3718
Retrospective Comparative Study of Side-by-Side and Stent-in-Stent Metal Stent Placement for Hilar Malignant Biliary Obstruction
Background In patients with unresectable hilar malignant biliary obstruction (MBO), bilateral metal stent placement is recommended. However, treatment selection between partially stent-in-stent (SIS) and side-by-side (SBS) methods is still controversial. Study Clinical outcomes of bilateral metal stent placement by SBS and SIS methods for hilar MBO were retrospectively studied in four Japanese centers. While large-cell-type uncovered metal stents were placed above the papilla in SIS, braided-type uncovered metal stents were placed across the papilla in SBS. Results A total of 64 patients with hilar MBO (40 SIS and 24 SBS) were included in the analysis. Technical success rate was 100% in SIS and 96% in SBS. Functional success rate was 93% in SIS and 96% in SBS. Early adverse event rates were higher in SBS (46%) than in SIS (23%), though not statistically significant (P = 0.09). Post-procedure pancreatitis was exclusively observed in SBS group (29%). Recurrent biliary obstruction rates were 48% and 43%, and the median time to recurrent biliary obstruction was 169 and 205 days in SIS and SBS, respectively. Conclusions Other than a trend to higher adverse event rates including post-procedure pancreatitis in SBS, clinical outcomes of SIS and SBS methods were comparable in patients with unresectable hilar MBO.
- 1 September 2016
- Published by Elsevier in European Journal of Cancer
- Vol. 65, 11-20
Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
- 1 September 2016
- Published by Elsevier in European Journal of Cancer
- Vol. 65, 11-20
Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
- 20 May 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (8) , 1931-1938
Transmural Biliary Drainage Can Be an Alternative to Transpapillary Drainage in Patients with an Indwelling Duodenal Stent
Self-expandable metal stents (SEMS) are widely utilized to relieve symptoms of malignant gastric outlet obstruction (GOO), but GOO is frequently complicated by nonresectable distal biliary obstruction. The optimal endoscopic approach to biliary drainage in this setting remains controversial and has yet to be resolved. To compare the safety and efficacy of endoscopic ultrasound-guided transmural biliary drainage (EUS-BD) and transpapillary drainage in patients with an indwelling duodenal SEMS. Patients who underwent EUS-BD or transpapillary drainage for distal malignant biliary obstruction with an indwelling duodenal SEMS between June 2007 and August 2012 at three Japanese tertiary referral centers were identified retrospectively. We compared times to stent dysfunction, causes of dysfunction, and procedural related complications between these two groups. Twenty patients were included in the study (7 EUS-BD and 13 transpapillary drainage). EUS-BD was performed via hepaticogastrostomy using a SEMS in three patients and via choledochoduodenostomy using a SEMS or a plastic stent in two patients each. Transpapillary drainage was performed using a SEMS in all patients. The stent patency rate in the EUS-BD group was higher than that in the transpapillary drainage group (100 vs. 71 % at 1 month and 83 vs. 29 % at 3 months, respectively). The rate of stent dysfunction in the EUS-BD group tended to be lower than that in the transpapillary group (14 vs. 54 %; P = 0.157). Complication rates were similar between the groups (P = 1.000), with moderate bleeding in one patient in the EUS-BD group and mild pancreatitis in one patient in the transpapillary group. Endoscopic ultrasound-guided transmural biliary drainage is an alternative to transpapillary drainage in patients with an indwelling duodenal SEMS.
- 20 May 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (8) , 1931-1938
Transmural Biliary Drainage Can Be an Alternative to Transpapillary Drainage in Patients with an Indwelling Duodenal Stent
Self-expandable metal stents (SEMS) are widely utilized to relieve symptoms of malignant gastric outlet obstruction (GOO), but GOO is frequently complicated by nonresectable distal biliary obstruction. The optimal endoscopic approach to biliary drainage in this setting remains controversial and has yet to be resolved. To compare the safety and efficacy of endoscopic ultrasound-guided transmural biliary drainage (EUS-BD) and transpapillary drainage in patients with an indwelling duodenal SEMS. Patients who underwent EUS-BD or transpapillary drainage for distal malignant biliary obstruction with an indwelling duodenal SEMS between June 2007 and August 2012 at three Japanese tertiary referral centers were identified retrospectively. We compared times to stent dysfunction, causes of dysfunction, and procedural related complications between these two groups. Twenty patients were included in the study (7 EUS-BD and 13 transpapillary drainage). EUS-BD was performed via hepaticogastrostomy using a SEMS in three patients and via choledochoduodenostomy using a SEMS or a plastic stent in two patients each. Transpapillary drainage was performed using a SEMS in all patients. The stent patency rate in the EUS-BD group was higher than that in the transpapillary drainage group (100 vs. 71 % at 1 month and 83 vs. 29 % at 3 months, respectively). The rate of stent dysfunction in the EUS-BD group tended to be lower than that in the transpapillary group (14 vs. 54 %; P = 0.157). Complication rates were similar between the groups (P = 1.000), with moderate bleeding in one patient in the EUS-BD group and mild pancreatitis in one patient in the transpapillary group. Endoscopic ultrasound-guided transmural biliary drainage is an alternative to transpapillary drainage in patients with an indwelling duodenal SEMS.
- 20 January 2014
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 46 (S 01) , E472-E473
Multiple metal stenting using a double-balloon endoscope for malignant biliary obstruction in a patient with hepaticojejunostomy
Endoscopic management of malignant biliary obstruction following hepaticojejunostomy can be challenging. With the advent of the short double-balloon endoscope (DBE), therapeutic biliary interventions are possible in surgically altered anatomy [1] [2]. Additionally, a novel uncovered metal stent (UMS) has been developed with a 200-cm-long, 6-Fr delivery system (Zilver 635; Cook Medical, Winston-Salem, North Carolina, United States) to enable metal stent placement using a short DBE [3]. We present a successful case of multiple metal stenting using a short DBE and UMS for malignant biliary obstruction after hepaticojejunostomy. A 75-year-old man with extrahepatic bile duct cancer underwent pancreaticoduodenectomy with Roux-en-Y reconstruction. He developed cholangitis 11 months postoperatively as a result of liver metastasis in the medial left lobe segment. Endoscopic retrograde cholangiopancreatography (ERCP) was performed to place two plastic stents using a short DBE (EI-530B; Fujifilm Corp., Tokyo, Japan). However, rapid tumor growth resulted in recurrent episodes of cholangitis. Therefore, the decision was made to insert multiple metal stents via another ERCP using the short DBE. The plastic stents were removed, and the hepaticojejunostomy anastomosis was cannulated. A 0.025-inch stiff guidewire (Revowave; Piolax Medical Devices, Yokohama, Japan) was placed into the anterior right hepatic duct branch, and the UMS was inserted using the 6-Fr delivery system ([Fig. 1]). A seeking guidewire (Radifocus; Terumo, Tokyo, Japan) sought the posterior right hepatic duct branch through the stent mesh, and the catheter was advanced through the stent mesh ([Fig. 2]). The guidewire was exchanged for a stiff guidewire. The second UMS was deployed ([Fig. 3]). Subsequently, a seeking guidewire sought the lateral left hepatic duct branch through the overlapping stent mesh. The catheter could then be passed through the overlapping stent mesh ([Fig. 4]). The guidewire was exchanged. Finally, the third UMS was smoothly deployed into the lateral left hepatic duct using a stent-in-stent method ([Fig. 5]). Endoscopy_UCTN_Code_TTT_1AR_2AZ
- 20 January 2014
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 46 (S 01) , E472-E473
Multiple metal stenting using a double-balloon endoscope for malignant biliary obstruction in a patient with hepaticojejunostomy
Endoscopic management of malignant biliary obstruction following hepaticojejunostomy can be challenging. With the advent of the short double-balloon endoscope (DBE), therapeutic biliary interventions are possible in surgically altered anatomy [1] [2]. Additionally, a novel uncovered metal stent (UMS) has been developed with a 200-cm-long, 6-Fr delivery system (Zilver 635; Cook Medical, Winston-Salem, North Carolina, United States) to enable metal stent placement using a short DBE [3]. We present a successful case of multiple metal stenting using a short DBE and UMS for malignant biliary obstruction after hepaticojejunostomy. A 75-year-old man with extrahepatic bile duct cancer underwent pancreaticoduodenectomy with Roux-en-Y reconstruction. He developed cholangitis 11 months postoperatively as a result of liver metastasis in the medial left lobe segment. Endoscopic retrograde cholangiopancreatography (ERCP) was performed to place two plastic stents using a short DBE (EI-530B; Fujifilm Corp., Tokyo, Japan). However, rapid tumor growth resulted in recurrent episodes of cholangitis. Therefore, the decision was made to insert multiple metal stents via another ERCP using the short DBE. The plastic stents were removed, and the hepaticojejunostomy anastomosis was cannulated. A 0.025-inch stiff guidewire (Revowave; Piolax Medical Devices, Yokohama, Japan) was placed into the anterior right hepatic duct branch, and the UMS was inserted using the 6-Fr delivery system ([Fig. 1]). A seeking guidewire (Radifocus; Terumo, Tokyo, Japan) sought the posterior right hepatic duct branch through the stent mesh, and the catheter was advanced through the stent mesh ([Fig. 2]). The guidewire was exchanged for a stiff guidewire. The second UMS was deployed ([Fig. 3]). Subsequently, a seeking guidewire sought the lateral left hepatic duct branch through the overlapping stent mesh. The catheter could then be passed through the overlapping stent mesh ([Fig. 4]). The guidewire was exchanged. Finally, the third UMS was smoothly deployed into the lateral left hepatic duct using a stent-in-stent method ([Fig. 5]). Endoscopy_UCTN_Code_TTT_1AR_2AZ
- 1 January 2013
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 49 (1) , 121-128
Short- and long-term outcomes of endoscopic papillary large balloon dilation with or without sphincterotomy for removal of large bile duct stones
Objective. Removal of large bile duct stones by endoscopic papillary large balloon dilation (EPLBD) with endoscopic sphincterotomy (EST) has been proven safe and effective. Little evidence supports the benefits of a preceding EST in reducing complications. Recent studies suggest that large bile duct stone removal by EPLBD alone may be safe and effective. Material and methods. We removed large bile duct stones by EPLBD with EST from March 2008 to February 2010 and without EST from March 2010 to October 2011. Efficacy and safety of EPLBD with or without EST and late biliary complication outcomes were assessed. Results. Forty-two patients (men/women, 27/15; mean age, 76 years) underwent EPLBD: 14 underwent EPLBD with EST and 28 underwent EPLBD without EST. The mean stone size was 14 mm (9–30 mm). Overall complete stone removal rate was 98%, with 83% achieved in 1 session. Complete duct clearance by EPLBD alone was achieved in 79%. Mechanical lithotripsy was required in 4 (10%) patients. Extracorporeal shock wave lithotripsy and electrohydraulic lithotripsy were required in 4 (10%) and 1 (2%) patients, respectively. Pancreatitis and perforation occurred in 2 (5%) and 1 (2%) patients, respectively. Patients treated by EPLBD with EST and by EPLBD alone did not differ in complication outcomes. Six (14%) patients had recurrent bile duct stones, with a significant correlation to dilated common bile duct (p = 0.0351). Conclusions. EPLBD is safe and effective in patients with large bile duct stones. Preceding EST may be unnecessary.
- 1 January 2013
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 49 (1) , 121-128
Short- and long-term outcomes of endoscopic papillary large balloon dilation with or without sphincterotomy for removal of large bile duct stones
Objective. Removal of large bile duct stones by endoscopic papillary large balloon dilation (EPLBD) with endoscopic sphincterotomy (EST) has been proven safe and effective. Little evidence supports the benefits of a preceding EST in reducing complications. Recent studies suggest that large bile duct stone removal by EPLBD alone may be safe and effective. Material and methods. We removed large bile duct stones by EPLBD with EST from March 2008 to February 2010 and without EST from March 2010 to October 2011. Efficacy and safety of EPLBD with or without EST and late biliary complication outcomes were assessed. Results. Forty-two patients (men/women, 27/15; mean age, 76 years) underwent EPLBD: 14 underwent EPLBD with EST and 28 underwent EPLBD without EST. The mean stone size was 14 mm (9–30 mm). Overall complete stone removal rate was 98%, with 83% achieved in 1 session. Complete duct clearance by EPLBD alone was achieved in 79%. Mechanical lithotripsy was required in 4 (10%) patients. Extracorporeal shock wave lithotripsy and electrohydraulic lithotripsy were required in 4 (10%) and 1 (2%) patients, respectively. Pancreatitis and perforation occurred in 2 (5%) and 1 (2%) patients, respectively. Patients treated by EPLBD with EST and by EPLBD alone did not differ in complication outcomes. Six (14%) patients had recurrent bile duct stones, with a significant correlation to dilated common bile duct (p = 0.0351). Conclusions. EPLBD is safe and effective in patients with large bile duct stones. Preceding EST may be unnecessary.
- 10 February 2012
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 44 (S 02) , E145-E146
Cholesterolosis of the gallbladder visualized by peroral cholecystoscopy using a SpyGlass probe
It is difficult to distinguish malignant gallbladder diseases from benign ones preoperatively, even though appropriate imaging techniques have been developed [1]. Therefore complementary techniques which facilitate direct visual assessment and visually guided tissue sampling are desirable. We describe the first case of gallbladder cholesterolosis successfully visualized and diagnosed by peroral cholecystoscopy using a SpyGlass probe (Boston Scientific, Natick, Massachusetts, USA) in a patient with pancreatobiliary maljunction. A previously healthy 42-year-old woman presented at our institution with intermittent right upper abdominal pain. Abdominal ultrasonography and computed tomography showed a dilated cystic duct and polypoid lesions with circumferential wall thickness in the gallbladder. Endoscopic retrograde cholangiopancreatography (ERCP) revealed pancreatobiliary maljunction with cystic duct dilatation ([Fig. 1]). After a Tandem XL cannula (Boston Scientific) was advanced into the gallbladder, a SpyGlass probe was inserted through the catheter. Peroral cholecystoscopy showed numerous yellowish polypoid lesions resembling a strawberry in the gallbladder ([Fig. 2] and [Video 1]). Transpapillary biopsy specimens of the gallbladder showed cholesterolosis, which was characterized by clusters of foamy macrophages in the lamina propria ([Fig. 3]). The patient underwent resection of the extrahepatic bile duct and gallbladder with hepaticojejunostomy. A surgical specimen revealed that cholesterolosis had spread extensively to the gallbladder and bile duct, without there being a malignant lesion ([Fig. 4]). There have been previous reports of peroral cholecystoscopy; however, the technique has not been widely accepted, because of technical difficulties [2]. The SpyGlass Direct Visualization System (Boston Scientific), which is a newly developed peroral cholangiopancreatoscopy system, provides improvements in the diagnosis and therapy of various pancreatobiliary diseases [3]. The SpyGlass probe can be used through a conventional ERCP catheter, so peroral cholecystoscopy can be performed easily even when the diameter of the bile duct or cystic duct is too small for conventional cholangioscopy. Thus this technique may expand the diagnostic possibilities in diseases of the gallbladder. Endoscopy_UCTN_Code_CCL_1AZ_2AI
- 10 February 2012
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 44 (S 02) , E145-E146
Cholesterolosis of the gallbladder visualized by peroral cholecystoscopy using a SpyGlass probe
It is difficult to distinguish malignant gallbladder diseases from benign ones preoperatively, even though appropriate imaging techniques have been developed [1]. Therefore complementary techniques which facilitate direct visual assessment and visually guided tissue sampling are desirable. We describe the first case of gallbladder cholesterolosis successfully visualized and diagnosed by peroral cholecystoscopy using a SpyGlass probe (Boston Scientific, Natick, Massachusetts, USA) in a patient with pancreatobiliary maljunction. A previously healthy 42-year-old woman presented at our institution with intermittent right upper abdominal pain. Abdominal ultrasonography and computed tomography showed a dilated cystic duct and polypoid lesions with circumferential wall thickness in the gallbladder. Endoscopic retrograde cholangiopancreatography (ERCP) revealed pancreatobiliary maljunction with cystic duct dilatation ([Fig. 1]). After a Tandem XL cannula (Boston Scientific) was advanced into the gallbladder, a SpyGlass probe was inserted through the catheter. Peroral cholecystoscopy showed numerous yellowish polypoid lesions resembling a strawberry in the gallbladder ([Fig. 2] and [Video 1]). Transpapillary biopsy specimens of the gallbladder showed cholesterolosis, which was characterized by clusters of foamy macrophages in the lamina propria ([Fig. 3]). The patient underwent resection of the extrahepatic bile duct and gallbladder with hepaticojejunostomy. A surgical specimen revealed that cholesterolosis had spread extensively to the gallbladder and bile duct, without there being a malignant lesion ([Fig. 4]). There have been previous reports of peroral cholecystoscopy; however, the technique has not been widely accepted, because of technical difficulties [2]. The SpyGlass Direct Visualization System (Boston Scientific), which is a newly developed peroral cholangiopancreatoscopy system, provides improvements in the diagnosis and therapy of various pancreatobiliary diseases [3]. The SpyGlass probe can be used through a conventional ERCP catheter, so peroral cholecystoscopy can be performed easily even when the diameter of the bile duct or cystic duct is too small for conventional cholangioscopy. Thus this technique may expand the diagnostic possibilities in diseases of the gallbladder. Endoscopy_UCTN_Code_CCL_1AZ_2AI
- 21 October 2011
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 43 (S 02) , E334-E335
Hemobilia as a rare complication after endoscopic ultrasound-guided fine-needle aspiration for hilar cholangiocarcinoma
Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a useful and safe procedure for obtaining tissue samples for the diagnosis of lesions adjacent to the gastrointestinal tract [ 1 ] [ 2 ]. We describe a first case of hemobilia presenting as obstructive jaundice after EUS-FNA for hilar cholangiocarcinoma. A 67-year-old man presented at our institution with malaise. Abdominal magnetic resonance imaging (MRI) and EUS (EG-530 UT2; Fujifilm, Tokyo, Japan) showed a hilar bile duct tumor ([ Fig. 1 ]); however, the patient’s serum bilirubin level was normal. Fig. 1 a Magnetic resonance image showing a low-intensity mass at the hilar region (arrow). b Endoscopic ultrasound (EUS) image showing hypoechoic tumor at the hilar bile duct (arrow). For obtaining tissue samples, we performed EUS-FNA on the hilar bile duct tumor from the duodenal bulb by using a 22-gauge needle (Echotip-Ultra; Wilson-Cook, Winston-Salem, North Carolina, USA). The pathological specimen revealed adenocarcinoma, and the patient was diagnosed with hilar cholangiocarcinoma. After 4 days, he complained of abdominal pain and icterus. A laboratory test revealed a serum bilirubin level of 6.6 mg/dL. Abdominal computed tomography (CT) showed that high-density fluid was retained in the gallbladder and common bile duct ([ Fig. 2 ]). Fig. 2 Abdominal computed tomography (CT) showing high-density fluid in: a the gallbladder (arrow) and b the lower bile duct (arrow). We suspected obstructive jaundice caused by hemobilia. A duodenoscope showed that blood was flowing out from the papilla ([ Fig. 3 ]). Fig. 3 Endoscopic image showing blood coming out from the papilla. We placed a 5-Fr endoscopic nasobiliary drainage (ENBD) tube for biliary drainage. Hemobilia subsided following conservative therapy, and the ENBD tube was removed after 8 days. Hemobilia is a rare complication after percutaneous liver biopsy [ 3 ]. The accidental laceration of an artery or a portal vein is considered to be the likely cause of hemobilia. Although EUS-FNA of bile duct tumors has been reported frequently [ 4 ], there were no reports of hemobilia as a complication of EUS-FNA. In our patient, hemobilia occurred 4 days after EUS-FNA, which was within the previously reported range in which hemobilia developed after liver biopsy [ 3 ]. Endoscopic retrograde cholangiopancreatography (ERCP) can successfully visualize blood coming out from the papilla. Although, in our case, hemobilia resolved with ENBD tube insertion, transarterial embolization or surgery may be sometimes necessary for its management [ 5 ]. Endoscopy_UCTN_Code_CPL_1AL_2AF
- 21 October 2011
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 43 (S 02) , E334-E335
Hemobilia as a rare complication after endoscopic ultrasound-guided fine-needle aspiration for hilar cholangiocarcinoma
Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a useful and safe procedure for obtaining tissue samples for the diagnosis of lesions adjacent to the gastrointestinal tract [ 1 ] [ 2 ]. We describe a first case of hemobilia presenting as obstructive jaundice after EUS-FNA for hilar cholangiocarcinoma. A 67-year-old man presented at our institution with malaise. Abdominal magnetic resonance imaging (MRI) and EUS (EG-530 UT2; Fujifilm, Tokyo, Japan) showed a hilar bile duct tumor ([ Fig. 1 ]); however, the patient’s serum bilirubin level was normal. Fig. 1 a Magnetic resonance image showing a low-intensity mass at the hilar region (arrow). b Endoscopic ultrasound (EUS) image showing hypoechoic tumor at the hilar bile duct (arrow). For obtaining tissue samples, we performed EUS-FNA on the hilar bile duct tumor from the duodenal bulb by using a 22-gauge needle (Echotip-Ultra; Wilson-Cook, Winston-Salem, North Carolina, USA). The pathological specimen revealed adenocarcinoma, and the patient was diagnosed with hilar cholangiocarcinoma. After 4 days, he complained of abdominal pain and icterus. A laboratory test revealed a serum bilirubin level of 6.6 mg/dL. Abdominal computed tomography (CT) showed that high-density fluid was retained in the gallbladder and common bile duct ([ Fig. 2 ]). Fig. 2 Abdominal computed tomography (CT) showing high-density fluid in: a the gallbladder (arrow) and b the lower bile duct (arrow). We suspected obstructive jaundice caused by hemobilia. A duodenoscope showed that blood was flowing out from the papilla ([ Fig. 3 ]). Fig. 3 Endoscopic image showing blood coming out from the papilla. We placed a 5-Fr endoscopic nasobiliary drainage (ENBD) tube for biliary drainage. Hemobilia subsided following conservative therapy, and the ENBD tube was removed after 8 days. Hemobilia is a rare complication after percutaneous liver biopsy [ 3 ]. The accidental laceration of an artery or a portal vein is considered to be the likely cause of hemobilia. Although EUS-FNA of bile duct tumors has been reported frequently [ 4 ], there were no reports of hemobilia as a complication of EUS-FNA. In our patient, hemobilia occurred 4 days after EUS-FNA, which was within the previously reported range in which hemobilia developed after liver biopsy [ 3 ]. Endoscopic retrograde cholangiopancreatography (ERCP) can successfully visualize blood coming out from the papilla. Although, in our case, hemobilia resolved with ENBD tube insertion, transarterial embolization or surgery may be sometimes necessary for its management [ 5 ]. Endoscopy_UCTN_Code_CPL_1AL_2AF
- 13 August 2011
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 46 (12) , 1411-1417
Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage
The current management of acute cholangitis consists of antibiotic therapy in combination with biliary drainage. However, the optimal duration of antibiotic therapy after the resolution of clinical symptoms by biliary drainage is unclear. We aimed to evaluate whether discontinuing antibiotic therapy for acute cholangitis immediately after the resolution of clinical symptoms, achieved by endoscopic biliary drainage, was safe and effective.
- 13 August 2011
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 46 (12) , 1411-1417
Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage
The current management of acute cholangitis consists of antibiotic therapy in combination with biliary drainage. However, the optimal duration of antibiotic therapy after the resolution of clinical symptoms by biliary drainage is unclear. We aimed to evaluate whether discontinuing antibiotic therapy for acute cholangitis immediately after the resolution of clinical symptoms, achieved by endoscopic biliary drainage, was safe and effective.
- 11 August 2011
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 43 (S 02) , E241-E242
Peroral cholangioscopy in a patient with a Billroth II gastrectomy using the SpyGlass Direct Visualization System
Peroral cholangioscopy in patients with altered gastrointestinal anatomy is challenging because of the technical difficulties associated with accessing the papilla and the high rate of complications experienced when using a side-viewing duodenoscope [ 1 ]. The recently developed SpyGlass Direct Visualization System (Microvasive Endoscopy, Boston Scientific, Natick, Massachusetts, USA) can be passed through a forward-viewing endoscope because its diameter is 10 Fr [ 2 ] [ 3 ] [ 4 ]. We describe a case of cholangiocarcinoma that was successfully visualized using a SpyGlass cholangioscope in a patient with a Billroth II gastrectomy. An 81-year-old man presented to our institution for evaluation of obstructive jaundice. His medical history included a Billroth II gastrectomy for gastric cancer 10 years previously. A front-viewing endoscope was passed through the afferent limb reaching the papilla without difficulty. A cholangiogram showed a severe stricture at the lower end of the bile duct ([ Fig. 1 ]). Fig. 1 Cholangiogram showing a stricture at the lower end of the bile duct. Following endoscopic papillary balloon dilation, a SpyGlass cholangioscope was passed into the bile duct without difficulty ([ Fig. 2 ]). Fig. 2 Fluoroscopy showing the SpyGlass cholangioscope inside the bile duct, having been passed through the forward-viewing endoscope. Cholangioscopy showed an irregular, fine granular lesion at the upper end of the stricture and normal mucosa at the hilar bile duct ([ Fig. 3 ]), both of which were biopsied under cholangioscopic imaging using a 3-Fr SpyBite forceps (Boston Scientific; [ Video 1 ]). Fig. 3 Cholangioscopy showing: a an irregular, fine granular lesion at the upper end of the stricture; b normal mucosa at the hilar bile duct. The biopsy specimens taken from the irregular lesion showed adenocarcinoma, whereas those from the hilar bile duct showed no malignancy. He was diagnosed as having a lower bile duct carcinoma without intraepithelial spread of tumor to the hilar bile duct and underwent pancreatoduodenectomy at our hospital. Peroral cholangioscopy with mapping biopsies has been shown to be effective for the diagnosis of intraepithelial tumor spread in cholangiocarcinoma [ 5 ]. Although SpyGlass cholangioscopy through a colonoscope has been reported in patients with a Roux-en-Y anastomosis [ 3 ] [ 4 ], to our knowledge, this is the first case of bile duct biopsy under direct visualization by SpyGlass cholangioscope in a patient with a Billroth II gastrectomy. In summary, SpyGlass cholangioscopy through a forward-viewing endoscope was very useful for the diagnosis of cholangiocarcinoma in a patient with a Billroth II gastrectomy. Endoscopy_UCTN_Code_TTT_1AR_2AB
- 11 August 2011
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 43 (S 02) , E241-E242
Peroral cholangioscopy in a patient with a Billroth II gastrectomy using the SpyGlass Direct Visualization System
Peroral cholangioscopy in patients with altered gastrointestinal anatomy is challenging because of the technical difficulties associated with accessing the papilla and the high rate of complications experienced when using a side-viewing duodenoscope [ 1 ]. The recently developed SpyGlass Direct Visualization System (Microvasive Endoscopy, Boston Scientific, Natick, Massachusetts, USA) can be passed through a forward-viewing endoscope because its diameter is 10 Fr [ 2 ] [ 3 ] [ 4 ]. We describe a case of cholangiocarcinoma that was successfully visualized using a SpyGlass cholangioscope in a patient with a Billroth II gastrectomy. An 81-year-old man presented to our institution for evaluation of obstructive jaundice. His medical history included a Billroth II gastrectomy for gastric cancer 10 years previously. A front-viewing endoscope was passed through the afferent limb reaching the papilla without difficulty. A cholangiogram showed a severe stricture at the lower end of the bile duct ([ Fig. 1 ]). Fig. 1 Cholangiogram showing a stricture at the lower end of the bile duct. Following endoscopic papillary balloon dilation, a SpyGlass cholangioscope was passed into the bile duct without difficulty ([ Fig. 2 ]). Fig. 2 Fluoroscopy showing the SpyGlass cholangioscope inside the bile duct, having been passed through the forward-viewing endoscope. Cholangioscopy showed an irregular, fine granular lesion at the upper end of the stricture and normal mucosa at the hilar bile duct ([ Fig. 3 ]), both of which were biopsied under cholangioscopic imaging using a 3-Fr SpyBite forceps (Boston Scientific; [ Video 1 ]). Fig. 3 Cholangioscopy showing: a an irregular, fine granular lesion at the upper end of the stricture; b normal mucosa at the hilar bile duct. The biopsy specimens taken from the irregular lesion showed adenocarcinoma, whereas those from the hilar bile duct showed no malignancy. He was diagnosed as having a lower bile duct carcinoma without intraepithelial spread of tumor to the hilar bile duct and underwent pancreatoduodenectomy at our hospital. Peroral cholangioscopy with mapping biopsies has been shown to be effective for the diagnosis of intraepithelial tumor spread in cholangiocarcinoma [ 5 ]. Although SpyGlass cholangioscopy through a colonoscope has been reported in patients with a Roux-en-Y anastomosis [ 3 ] [ 4 ], to our knowledge, this is the first case of bile duct biopsy under direct visualization by SpyGlass cholangioscope in a patient with a Billroth II gastrectomy. In summary, SpyGlass cholangioscopy through a forward-viewing endoscope was very useful for the diagnosis of cholangiocarcinoma in a patient with a Billroth II gastrectomy. Endoscopy_UCTN_Code_TTT_1AR_2AB
- 11 August 2011
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 43 (S 02) , E272
Noncalcified pancreatic stone treated with electrohydraulic lithotripsy using SpyGlass pancreatoscopy
Endoscopic removal of pancreatic stones remains challenging, especially when the stones are larger than 1 cm in diameter. Although electrohydraulic lithotripsy (EHL) with a baby endoscope is useful in some cases [ 1 ], it can be difficult because of poor operability of the baby scope or incomplete irrigation with the EHL probe loaded in the working channel of the scope. Recently, the SpyGlass Direct Visualization System (SDVS; Boston Scientific, Natick, Massachusetts, USA) has allowed more effective diagnostic and therapeutic applications [ 2 ] [ 3 ]. Here we report the successful fragmentation of a large noncalcified pancreatic stone using SDVS-guided EHL. A 58-year-old man with alcoholic chronic pancreatitis was referred to our hospital for management of recurrent pancreatitis. Computed tomography (CT) showed a noncalcified stone of 1.5 cm in diameter in the dilated main pancreatic duct ([ Fig. 1 ]). Fig. 1 Computed tomography (CT) scan showing a noncalcified stone of 1.5 cm in diameter in the dilated main pancreatic duct. Because of the difficulty of targeting noncalcified stones under fluoroscopic guidance for extracorporeal shockwave lithotripsy (ESWL), we employed EHL under the guidance of SpyGlass pancreatoscopy instead. Following pancreatic sphincterotomy and balloon dilation of a stricture within the main pancreatic duct in the head of the pancreas, a large white stone was visualized by SDVS although it was located just behind a bend within the duct ([ Fig. 2 ]). Fig. 2 View through the SpyGlass Direct Visualization System showing a large white stone in the main pancreatic duct. EHL was applied using a lithotriptor (Northgate Autolith; Nortech, Elgin, Illinois, USA) and the stone was disintegrated under direct visualization combined with frequent irrigation through the dedicated channel ([ Video 1 ]). Complete clearance of the main pancreatic duct was obtained and the patient was discharged with complete resolution of his pain. EHL for pancreatic stones guided by a conventional baby endoscope is very difficult because of poor visualization in the tortuous and narrow pancreatic duct and inefficient irrigation. As the SDVS has 4-way tip deflection and a dedicated irrigation channel, we were able to successfully perform fragmentation of the pancreatic stones by SDVS-guided EHL. The efficacy of SDVS in the management of pancreatic stones needs to be assessed in further cases. Endoscopy_UCTN_Code_TTT_1AR_2AH
- 11 August 2011
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 43 (S 02) , E272
Noncalcified pancreatic stone treated with electrohydraulic lithotripsy using SpyGlass pancreatoscopy
Endoscopic removal of pancreatic stones remains challenging, especially when the stones are larger than 1 cm in diameter. Although electrohydraulic lithotripsy (EHL) with a baby endoscope is useful in some cases [ 1 ], it can be difficult because of poor operability of the baby scope or incomplete irrigation with the EHL probe loaded in the working channel of the scope. Recently, the SpyGlass Direct Visualization System (SDVS; Boston Scientific, Natick, Massachusetts, USA) has allowed more effective diagnostic and therapeutic applications [ 2 ] [ 3 ]. Here we report the successful fragmentation of a large noncalcified pancreatic stone using SDVS-guided EHL. A 58-year-old man with alcoholic chronic pancreatitis was referred to our hospital for management of recurrent pancreatitis. Computed tomography (CT) showed a noncalcified stone of 1.5 cm in diameter in the dilated main pancreatic duct ([ Fig. 1 ]). Fig. 1 Computed tomography (CT) scan showing a noncalcified stone of 1.5 cm in diameter in the dilated main pancreatic duct. Because of the difficulty of targeting noncalcified stones under fluoroscopic guidance for extracorporeal shockwave lithotripsy (ESWL), we employed EHL under the guidance of SpyGlass pancreatoscopy instead. Following pancreatic sphincterotomy and balloon dilation of a stricture within the main pancreatic duct in the head of the pancreas, a large white stone was visualized by SDVS although it was located just behind a bend within the duct ([ Fig. 2 ]). Fig. 2 View through the SpyGlass Direct Visualization System showing a large white stone in the main pancreatic duct. EHL was applied using a lithotriptor (Northgate Autolith; Nortech, Elgin, Illinois, USA) and the stone was disintegrated under direct visualization combined with frequent irrigation through the dedicated channel ([ Video 1 ]). Complete clearance of the main pancreatic duct was obtained and the patient was discharged with complete resolution of his pain. EHL for pancreatic stones guided by a conventional baby endoscope is very difficult because of poor visualization in the tortuous and narrow pancreatic duct and inefficient irrigation. As the SDVS has 4-way tip deflection and a dedicated irrigation channel, we were able to successfully perform fragmentation of the pancreatic stones by SDVS-guided EHL. The efficacy of SDVS in the management of pancreatic stones needs to be assessed in further cases. Endoscopy_UCTN_Code_TTT_1AR_2AH